PRAX — Praxis Precision Medicines Income Statement
0.000.00%
Last trade - 00:00- $819.64m
- $427.08m
- $8.55m
Annual income statement for Praxis Precision Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 2.45 | 8.55 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 62 | 167 | 215 | 129 | 209 |
| Operating Profit | -62 | -167 | -215 | -126 | -200 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -61.8 | -167 | -214 | -123 | -183 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -61.8 | -167 | -214 | -123 | -183 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -61.8 | -167 | -214 | -123 | -183 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -70.3 | -167 | -214 | -123 | -183 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -27.3 | -59 | -69.3 | -18.7 | -10.2 |